Global Duchenne Muscular Dystrophy Market Analysis 2016-2020 and Forecast 2021-2026
- Report Code : 99S2398241
- Published On: Mar, 2021
- Category : Healthcare & Pharma
- Pages : 81
-
Duchenne muscular dystrophy is an x-linked genetic disorder that affects mostly boys. In Duchenne, boys begin to show signs of muscle weakness as early as two to five years of age. The disease gradually weakens the skeletal or voluntary muscles in the arms, legs and trunk. Due to progressive muscle weakness, Duchenne patients are often wheelchair bound between the ages of seven and 13 years old. At a later stage, the boys' respiratory and cardiac muscles are also affected and for most boys, respiratory and cardiac failure are major causes of death, often prevalent by the age of 20.
The global Duchenne Muscular Dystrophy market size is estimated at xxx million USD with a CAGR xx% from 2016-2020 and is expected to reach xxx Million USD in 2021 with a CAGR xx% from 2021 to 2026. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Duchenne Muscular Dystrophy by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Deflazacort
Prednisone
Others
Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
PTC Therapeutics
Sarepta Therapeutics
Bristol-Myers Squibb
ITALFARMACO
BioMarin
Daiichi Sankyo
Solid Biosciences
Summit Therapeutics
FibroGen
NS Pharma
Pfizer
ReveraGen BioPharma
Wave Life
Genethon
Santhera Pharmaceuticals
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Male
Female
Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
-
With tables and figures helping analyze worldwide Global Duchenne Muscular Dystrophy market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
1 Industry Overview1.1 Duchenne Muscular Dystrophy Industry
Figure Duchenne Muscular Dystrophy Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Duchenne Muscular Dystrophy1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Duchenne Muscular Dystrophy
1.2.2 Downstream
Table Application Segment of Duchenne Muscular Dystrophy
Table Global Duchenne Muscular Dystrophy Market 2016-2026, by Application, in USD Million
1.2.3 COVID-19 Impact1.3 Cost Analysis
2 Industry Environment (PEST Analysis)2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Duchenne Muscular Dystrophy Market by Type3.1 By Type
3.1.1 Deflazacort
Table Major Company List of Deflazacort
3.1.2 Prednisone
Table Major Company List of Prednisone
3.1.3 Others
Table Major Company List of Others3.2 Market Size
Table Global Duchenne Muscular Dystrophy Market 2016-2020, by Type, in USD Million
Figure Global Duchenne Muscular Dystrophy Market Growth 2016-2020, by Type, in USD Million
Table Global Duchenne Muscular Dystrophy Market 2016-2020, by Type, in Volume
Figure Global Duchenne Muscular Dystrophy Market Growth 2016-2020, by Type, in Volume3.3 Market Forecast
Table Global Duchenne Muscular Dystrophy Market Forecast 2021-2026, by Type, in USD Million
Table Global Duchenne Muscular Dystrophy Market Forecast 2021-2026, by Type, in Volume
4 Major Companies List4.1 PTC Therapeutics (Company Profile, Sales Data etc.)
4.1.1 PTC Therapeutics Profile
Table PTC Therapeutics Overview List
4.1.2 PTC Therapeutics Products & Services
4.1.3 PTC Therapeutics Business Operation Conditions
Table Business Operation of PTC Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)4.2 Sarepta Therapeutics (Company Profile, Sales Data etc.)
4.2.1 Sarepta Therapeutics Profile
Table Sarepta Therapeutics Overview List
4.2.2 Sarepta Therapeutics Products & Services
4.2.3 Sarepta Therapeutics Business Operation Conditions
Table Business Operation of Sarepta Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)4.3 Bristol-Myers Squibb (Company Profile, Sales Data etc.)
4.3.1 Bristol-Myers Squibb Profile
Table Bristol-Myers Squibb Overview List
4.3.2 Bristol-Myers Squibb Products & Services
4.3.3 Bristol-Myers Squibb Business Operation Conditions
Table Business Operation of Bristol-Myers Squibb (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)4.4 ITALFARMACO (Company Profile, Sales Data etc.)
4.4.1 ITALFARMACO Profile
Table ITALFARMACO Overview List
4.4.2 ITALFARMACO Products & Services
4.4.3 ITALFARMACO Business Operation Conditions
Table Business Operation of ITALFARMACO (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)4.5 BioMarin (Company Profile, Sales Data etc.)
4.5.1 BioMarin Profile
Table BioMarin Overview List
4.5.2 BioMarin Products & Services
4.5.3 BioMarin Business Operation Conditions
Table Business Operation of BioMarin (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)4.6 Daiichi Sankyo (Company Profile, Sales Data etc.)
4.6.1 Daiichi Sankyo Profile
Table Daiichi Sankyo Overview List
4.6.2 Daiichi Sankyo Products & Services
4.6.3 Daiichi Sankyo Business Operation Conditions
Table Business Operation of Daiichi Sankyo (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 Solid Biosciences (Company Profile, Sales Data etc.)
4.7.1 Solid Biosciences Profile
Table Solid Biosciences Overview List
4.7.2 Solid Biosciences Products & Services
4.7.3 Solid Biosciences Business Operation Conditions
Table Business Operation of Solid Biosciences (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 Summit Therapeutics (Company Profile, Sales Data etc.)
4.8.1 Summit Therapeutics Profile
Table Summit Therapeutics Overview List
4.8.2 Summit Therapeutics Products & Services
4.8.3 Summit Therapeutics Business Operation Conditions
Table Business Operation of Summit Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.9 FibroGen (Company Profile, Sales Data etc.)
4.9.1 FibroGen Profile
Table FibroGen Overview List
4.9.2 FibroGen Products & Services
4.9.3 FibroGen Business Operation Conditions
Table Business Operation of FibroGen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)4.10 NS Pharma (Company Profile, Sales Data etc.)
4.10.1 NS Pharma Profile
Table NS Pharma Overview List
4.10.2 NS Pharma Products & Services
4.10.3 NS Pharma Business Operation Conditions
Table Business Operation of NS Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.11 Pfizer (Company Profile, Sales Data etc.)
4.11.1 Pfizer Profile
Table Pfizer Overview List
4.11.2 Pfizer Products & Services
4.11.3 Pfizer Business Operation Conditions
Table Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.12 ReveraGen BioPharma (Company Profile, Sales Data etc.)
4.12.1 ReveraGen BioPharma Profile
Table ReveraGen BioPharma Overview List
4.12.2 ReveraGen BioPharma Products & Services
4.12.3 ReveraGen BioPharma Business Operation Conditions
Table Business Operation of ReveraGen BioPharma (Sales Revenue, Cost, Gross Margin)
4.13 Wave Life (Company Profile, Sales Data etc.)
4.13.1 Wave Life Profile
Table Wave Life Overview List
4.13.2 Wave Life Products & Services
4.13.3 Wave Life Business Operation Conditions
Table Business Operation of Wave Life (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.14 Genethon (Company Profile, Sales Data etc.)
4.14.1 Genethon Profile
Table Genethon Overview List
4.14.2 Genethon Products & Services
4.14.3 Genethon Business Operation Conditions
Table Business Operation of Genethon (Sales Revenue, Cost, Gross Margin)
4.15 Santhera Pharmaceuticals (Company Profile, Sales Data etc.)
4.15.1 Santhera Pharmaceuticals Profile
Table Santhera Pharmaceuticals Overview List
4.15.2 Santhera Pharmaceuticals Products & Services
4.15.3 Santhera Pharmaceuticals Business Operation Conditions
Table Business Operation of Santhera Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
5 Market Competition5.1 Company Competition
Table Global Duchenne Muscular Dystrophy Sales Revenue 2016-2020, by Company, in USD Million
Table Global Duchenne Muscular Dystrophy Sales Revenue Share 2016-2020, by Company, in USD Million
Figure Global Duchenne Muscular Dystrophy Sales Revenue Share in 2020, by Company, in USD Million
Table Global Duchenne Muscular Dystrophy Sales Volume 2016-2020, by Company, in Volume
Table Global Duchenne Muscular Dystrophy Sales Volume Share 2016-2020, by Company, in Volume
Figure Global Duchenne Muscular Dystrophy Sales Volume Share in 2020, by Company, in Volume5.2 Regional Market by Company
Figure North America Duchenne Muscular Dystrophy Market Concentration, in 2020
Figure Europe Duchenne Muscular Dystrophy Market Market Concentration, in 2020
Figure Asia-Pacific Duchenne Muscular Dystrophy MMarket Concentration, in 2020
Figure South America Duchenne Muscular Dystrophy Market Concentration, in 2020
Figure Middle East & Africa Duchenne Muscular Dystrophy Market Concentration, in 2020
6 Demand by End Market6.1 Demand Situation
6.1.1 Demand in Male
Figure Duchenne Muscular Dystrophy Demand in Male, 2016-2020, in USD Million
Figure Duchenne Muscular Dystrophy Demand in Male, 2016-2020, in Volume
6.1.2 Demand in Female
Figure Duchenne Muscular Dystrophy Demand in Female, 2016-2020, in USD Million
Figure Duchenne Muscular Dystrophy Demand in Female, 2016-2020, in Volume6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions6.3 Demand Forecast
Table Duchenne Muscular Dystrophy Demand Forecast 2021-2026, by Application, in USD Million
Figure Duchenne Muscular Dystrophy Market Growth 2021-2026, by Application, in USD Million
Figure Duchenne Muscular Dystrophy Market Share in 2026, by Application, in USD Million
Table Duchenne Muscular Dystrophy Demand Forecast 2021-2026, by Application, in Volume
Table Duchenne Muscular Dystrophy Market Growth 2021-2026, by Application, in Volume
Table Duchenne Muscular Dystrophy Market Share in 2026, by Application, in Volume6.4 Impact of the COVID-19 on the Demand
7 Region Operation7.1 Regional Production
Table Duchenne Muscular Dystrophy Production 2016-2020, by Region, in USD Million
Table Duchenne Muscular Dystrophy Production 2016-2020, by Region, in Volume7.2 Regional Market
Table Global Duchenne Muscular Dystrophy Market 2016-2020, by Region, in USD Million
Table Global Duchenne Muscular Dystrophy Market Share 2016-2020, by Region, in USD Million
Table Global Duchenne Muscular Dystrophy Market 2016-2020, by Region, in Volume
Table Global Duchenne Muscular Dystrophy Market Share 2016-2020, by Region, in Volume7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Duchenne Muscular Dystrophy Market Size and Growth 2016-2020, in USD Million
Figure North America Duchenne Muscular Dystrophy Market Size and Growth 2016-2020, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Duchenne Muscular Dystrophy Market Size 2016-2020, by Country, in USD Million
Table North America Duchenne Muscular Dystrophy Market Size 2016-2020, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Duchenne Muscular Dystrophy Market Size and Growth 2016-2020, in USD Million
Figure Europe Duchenne Muscular Dystrophy Market Size and Growth 2016-2020, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Duchenne Muscular Dystrophy Market Size 2016-2020, by Country, in USD Million
Table Europe Duchenne Muscular Dystrophy Market Size 2016-2020, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Duchenne Muscular Dystrophy Market Size and Growth 2016-2020, in USD Million
Figure Asia-Pacific Duchenne Muscular Dystrophy Market Size and Growth 2016-2020, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Duchenne Muscular Dystrophy Market Size 2016-2020, by Country, in USD Million
Table Asia-Pacific Duchenne Muscular Dystrophy Market Size 2016-2020, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Duchenne Muscular Dystrophy Market Size and Growth 2016-2020, in USD Million
Figure South America Duchenne Muscular Dystrophy Market Size and Growth 2016-2020, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Duchenne Muscular Dystrophy Market Size 2016-2020, by Country, in USD Million
Table South America Duchenne Muscular Dystrophy Market Size 2016-2020, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Duchenne Muscular Dystrophy Market Size and Growth 2016-2020, in USD Million
Figure Middle East & Africa Duchenne Muscular Dystrophy Market Size and Growth 2016-2020, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Duchenne Muscular Dystrophy Market Size 2016-2020, by Country, in USD Million
Table Middle East & Africa Duchenne Muscular Dystrophy Market Size 2016-2020, by Country, in Volume7.4 Regional Import & Export
7.5 Regional Forecast
Table Duchenne Muscular Dystrophy Market Forecast 2021-2026, by Region, in USD Million
Table Duchenne Muscular Dystrophy Market Forecast 2021-2026, by Region, in Volume
8 Marketing & Price8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion
-
The Global Duchenne Muscular Dystrophy Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.
Report Objectives / Segmentation Covered :
By Companies / players:
By Regions:
By Type:
By Application:
Frequently asked questions(FAQ's):
The flow of investment into the Global Duchenne Muscular Dystrophy Market, which is utilizing technologies to drive efficiency and high volume, clearly shows the market opportunity.
Depending upon the type of applications, the Global Duchenne Muscular Dystrophy Market has been segmented into
The Global Duchenne Muscular Dystrophy Market study evaluates the year spans as follows: Historical year: 2018 to 2023; Base year: 2023; Forecast period**: 2024 to 2029 [** unless otherwise stated]
Consumer behavior changes will reshape the entire decision-making process and companies in the Global Duchenne Muscular Dystrophy Industry will need to adapt quickly.
The Global Duchenne Muscular Dystrophy analysis provides high-level qualitative commentary on market dynamics, including information on growth drivers, influential trends, challenges, and opportunities.